scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Spatial Domains

Dominant neighborhood compartment and purity from Tier 1 domain summaries. Bulk files are centralized on the Download page.

251-300 of 2,070
Download spatial tables

Spatial Domains

Dominant neighborhood compartment and purity from Tier 1 domain summaries.

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__175_B7,9 Lung Primary cancer 3,924 Immune 23.9% 0.62 0.69
NSCLC_38242124__IMC__175_B8,1 Lung Primary cancer 2,457 Tumor/Malignant 48.8% 0.95 0.15
NSCLC_38242124__IMC__175_B8,10 Lung Primary cancer 2,512 Stromal 36.9% 0.47 0.81
NSCLC_38242124__IMC__175_B8,11 Lung Primary cancer 1,996 Stromal 26.0% 0.72 0.64
NSCLC_38242124__IMC__175_B8,12 Lung Primary cancer 4,012 Tumor/Malignant 69.9% 0.98 0.07
NSCLC_38242124__IMC__175_B8,13 Lung Primary cancer 2,892 Stromal 46.1% 0.75 0.54
NSCLC_38242124__IMC__175_B8,14 Lung Primary cancer 2,759 Tumor/Malignant 53.9% 0.94 0.20
NSCLC_38242124__IMC__175_B8,15 Lung Primary cancer 4,072 Tumor/Malignant 81.0% 0.96 0.12
NSCLC_38242124__IMC__175_B8,16 Lung Primary cancer 3,106 Other 25.7% 0.65 0.68
NSCLC_38242124__IMC__175_B8,17 Lung Primary cancer 3,192 Immune 51.0% 0.91 0.26
NSCLC_38242124__IMC__175_B8,2 Lung Primary cancer 3,741 Tumor/Malignant 42.6% 0.97 0.13
NSCLC_38242124__IMC__175_B8,3 Lung Primary cancer 891 Tumor/Malignant 27.7% 0.77 0.60
NSCLC_38242124__IMC__175_B8,4 Lung Primary cancer 2,257 Tumor/Malignant 38.1% 0.73 0.62
NSCLC_38242124__IMC__175_B8,5 Lung Primary cancer 5,087 Tumor/Malignant 72.1% 0.98 0.06
NSCLC_38242124__IMC__175_B8,6 Lung Primary cancer 4,367 Tumor/Malignant 29.7% 0.96 0.22
NSCLC_38242124__IMC__175_B8,7 Lung Primary cancer 2,512 Tumor/Malignant 34.0% 0.49 0.82
NSCLC_38242124__IMC__175_B8,8 Lung Primary cancer 3,952 Tumor/Malignant 35.8% 0.94 0.18
NSCLC_38242124__IMC__175_B8,9 Lung Primary cancer 4,684 Tumor/Malignant 55.7% 0.88 0.34
NSCLC_38242124__IMC__175_C1,1 Lung Primary cancer 5,194 Tumor/Malignant 48.5% 0.93 0.19
NSCLC_38242124__IMC__175_C1,10 Lung Primary cancer 4,235 Tumor/Malignant 61.5% 0.99 0.04
NSCLC_38242124__IMC__175_C1,11 Lung Primary cancer 3,589 Tumor/Malignant 36.5% 0.95 0.24
NSCLC_38242124__IMC__175_C1,12 Lung Primary cancer 2,616 Tumor/Malignant 69.6% 0.99 0.08
NSCLC_38242124__IMC__175_C1,13 Lung Primary cancer 2,103 Tumor/Malignant 29.4% 0.89 0.34
NSCLC_38242124__IMC__175_C1,14 Lung Primary cancer 3,235 Tumor/Malignant 67.3% 0.96 0.13
NSCLC_38242124__IMC__175_C1,15 Lung Primary cancer 2,953 Stromal 38.0% 0.80 0.48
NSCLC_38242124__IMC__175_C1,16 Lung Primary cancer 6,299 Immune 86.5% 0.99 0.04
NSCLC_38242124__IMC__175_C1,2 Lung Primary cancer 2,108 Immune 32.9% 0.48 0.92
NSCLC_38242124__IMC__175_C1,3 Lung Primary cancer 3,373 Tumor/Malignant 31.8% 0.93 0.27
NSCLC_38242124__IMC__175_C1,4 Lung Primary cancer 3,548 Immune 27.9% 0.46 0.83
NSCLC_38242124__IMC__175_C1,5 Lung Primary cancer 1,652 Tumor/Malignant 59.0% 0.96 0.10
NSCLC_38242124__IMC__175_C1,7 Lung Primary cancer 4,101 Tumor/Malignant 59.3% 0.99 0.08
NSCLC_38242124__IMC__175_C1,8 Lung Primary cancer 3,113 Immune 27.8% 0.85 0.42
NSCLC_38242124__IMC__175_C1,9 Lung Primary cancer 3,009 Tumor/Malignant 47.1% 0.99 0.04
NSCLC_38242124__IMC__175_C2,1 Lung Primary cancer 4,243 Tumor/Malignant 46.8% 0.89 0.30
NSCLC_38242124__IMC__175_C2,10 Lung Primary cancer 3,797 Tumor/Malignant 84.8% 0.99 0.03
NSCLC_38242124__IMC__175_C2,11 Lung Primary cancer 2,770 Tumor/Malignant 44.0% 0.92 0.30
NSCLC_38242124__IMC__175_C2,12 Lung Primary cancer 3,309 Tumor/Malignant 82.9% 0.99 0.04
NSCLC_38242124__IMC__175_C2,13 Lung Primary cancer 4,144 Immune 33.7% 0.84 0.38
NSCLC_38242124__IMC__175_C2,14 Lung Primary cancer 2,934 Tumor/Malignant 62.5% 0.97 0.11
NSCLC_38242124__IMC__175_C2,15 Lung Primary cancer 973 Immune 36.2% 0.43 0.85
NSCLC_38242124__IMC__175_C2,16 Lung Primary cancer 7,105 Immune 85.2% 0.98 0.05
NSCLC_38242124__IMC__175_C2,2 Lung Primary cancer 1,267 Tumor/Malignant 24.3% 0.54 0.92
NSCLC_38242124__IMC__175_C2,3 Lung Primary cancer 2,888 Tumor/Malignant 39.1% 0.95 0.20
NSCLC_38242124__IMC__175_C2,4 Lung Primary cancer 3,614 Immune 28.9% 0.42 0.85
NSCLC_38242124__IMC__175_C2,5 Lung Primary cancer 3,120 Tumor/Malignant 39.5% 0.92 0.28
NSCLC_38242124__IMC__175_C2,6 Lung Primary cancer 4,083 Tumor/Malignant 43.1% 0.99 0.05
NSCLC_38242124__IMC__175_C2,7 Lung Primary cancer 2,572 Tumor/Malignant 48.1% 0.97 0.12
NSCLC_38242124__IMC__175_C2,8 Lung Primary cancer 2,498 Tumor/Malignant 66.9% 0.96 0.14
NSCLC_38242124__IMC__175_C2,9 Lung Primary cancer 3,369 Tumor/Malignant 60.8% 0.96 0.13
NSCLC_38242124__IMC__175_C3,1 Lung Primary cancer 2,395 Tumor/Malignant 67.4% 0.95 0.16